This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Yeo, T. Articles by Lewis, L. Search for Related Content PubMed PubMed Citation Articles by Yeo, T. Articles by Lewis, L. Social Bookmarking                         What's this?

Sublethal concentrations of gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and function without reducing mitochondrial DNA content in BxPC-3 human pancreatic carcinoma cells

Section of Clinical Pharmacology, Department of Medicine, Dartmouth Medical School and Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA

J Kintner

Department of Pharmacology and Toxicology, Dartmouth Medical School and Dartmouth, Lebanon, NH 03756, USA

R Armand

Section of Clinical Pharmacology, Department of Medicine, Dartmouth Medical School and Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA

R Perez

Department of Pharmacology and Toxicology, Dartmouth Medical School and Dartmouth, Lebanon, NH 03756, USA; Section of Hematology/Oncology, Department of Medicine, Dartmouth Medical School and Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA

LD Lewis

Section of Clinical Pharmacology, Department of Medicine, Dartmouth Medical School and Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA; Department of Pharmacology and Toxicology, Dartmouth Medical School and Dartmouth, Lebanon, NH 03756, USA

2',2'-Difluorodeoxycytidine (gemcitabine), a pyrimidine nucleoside analog, is used therapeutically in the treatment of pancreatic, non-small cell lung, and breast cancer. The cytotoxic effect of gemcitabine is thought to be due to masked chain termination after the triphosphorylated anabolite of the drug is incorporated into nascent DNA strands. We tested the hypothesis that sublethal concentrations of gemcitabine inhibit DNA polymerase and reduce mitochondrial DNA content in BxPC-3 and MOLT-4 cell lines, and we used 2',3'-dideoxycytidine, a known inhibitor of DNA polymerase as a positive control. The 6-day BxPC-3 cell growth IC₅₀ for gemcitabine and 2',3'-dideoxycytidine was 0.003 µM (SD ± 0.0005) and 14.5 µM (SD ± 4.7), respectively, and in MOLT-4 cells was 0.002 µM (SD ± 0.001) and 0.86 µM (SD ± 0.23), respectively. These drug concentrations were anti-proliferative but non-cytotocidal. Electron photomicrographic studies showed deranged mitochondrial cristae patterns in BxPC-3 cells treated with either gemcitabine or 2',3'-dideoxycytidine for 6 days. Mitochondrial oxidative phosphorylation dysfunction was observed as reflected by increased lactate concentration in the media of cells exposed to gemcitabine, but to a much greater extent in cells exposed to 2',3'-dideoxycytidine. PCR analysis showed that gemcitabine did not reduce mitochondrial DNA content in either BxPC-3 or MOLT-4 cells, but 2',3'-dideoxycytidine did. The effect of gemcitabine on mitochondrial ultrastructure and function did not concomitantly yield a reduction in mitochondrial DNA content. Therefore, the molecular target(s) by which gemcitabine and 2',3'-dideoxycytidine produce mitochondrial abnormalities in these cells appear to be different.

Key Words: 2',3'-dideoxycytidine • BxPC-3 • MOLT-4 • gemcitabine • mitochondria

Human & Experimental Toxicology, Vol. 26, No. 12, 911-921 (2007)
DOI: 10.1177/0960327107086513


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				F. Liu, J. Yin, M. Du, P. Yan, J. Xu, X. Zhu, and J. Yu Heat-stress-induced damage to porcine small intestinal epithelium associated with downregulation of epithelial growth factor signaling J Anim Sci, June 1, 2009; 87(6): 1941 - 1949. [Abstract] [Full Text] [PDF]